Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 23, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

NIH Begins Early Human Clinical Trial of VSV Ebola Vaccine
Thursday, October 23, 2014
Human testing of a second investigational Ebola vaccine candidate is under way at the National Institutes of Health’s Clinical Center in Bethesda, Maryland.

Thermo Fisher Q3 Revenues up 31 Percent
Thursday, October 23, 2014
Thermo Fisher announced that revenues grew 31% to $4.17 billion for the third quarter ended September 27, 2014.

Funding for DNA Vaccines to Fight Infectious Disease
Wednesday, October 22, 2014
DARPA awards $12 million to Penn-led group to develop synthetic DNA vaccines to fight infectious disease.

Johnson & Johnson to Speed Ebola Vaccine Development, Significantly Expand Production
Wednesday, October 22, 2014
Company has committed up to $200M to vaccine program in development at its Janssen Pharmaceutical Companies.

Tekmira Provides Update on RNAi Therapeutic for Ebola
Tuesday, October 21, 2014
Company commences manufacture of new RNAi therapeutic for Ebola - Guinea variant.

Sanofi Pasteur and Immune Design Collaborate on a Vaccine to Treat HSV
Saturday, October 18, 2014
The two companies will develop a product jointly through phase II.

Peptide Mimics as a Drug Target for Ebola
Saturday, October 18, 2014
University of Utah researchers create a tool to develop treatments for Ebola using Protein Technologies’s peptide synthesizer.

Astrazeneca Strengthens Partnership with the University of Cambridge
Saturday, October 18, 2014
AstraZeneca and MedImmune have entered into four new collaborations.

Actavis to Acquire Durata Therapeutics, Inc.
Friday, October 17, 2014
Experienced development and commercial team bolsters Actavis' infectious disease expertise.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 1132
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv